Correlation Between Biovie and TG Therapeutics
Can any of the company-specific risk be diversified away by investing in both Biovie and TG Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Biovie and TG Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Biovie Inc and TG Therapeutics, you can compare the effects of market volatilities on Biovie and TG Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Biovie with a short position of TG Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Biovie and TG Therapeutics.
Diversification Opportunities for Biovie and TG Therapeutics
0.54 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Biovie and TGTX is 0.54. Overlapping area represents the amount of risk that can be diversified away by holding Biovie Inc and TG Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on TG Therapeutics and Biovie is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Biovie Inc are associated (or correlated) with TG Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of TG Therapeutics has no effect on the direction of Biovie i.e., Biovie and TG Therapeutics go up and down completely randomly.
Pair Corralation between Biovie and TG Therapeutics
Given the investment horizon of 90 days Biovie is expected to generate 3.42 times less return on investment than TG Therapeutics. In addition to that, Biovie is 1.11 times more volatile than TG Therapeutics. It trades about 0.07 of its total potential returns per unit of risk. TG Therapeutics is currently generating about 0.27 per unit of volatility. If you would invest 2,571 in TG Therapeutics on August 30, 2024 and sell it today you would earn a total of 929.00 from holding TG Therapeutics or generate 36.13% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 95.65% |
| Values | Daily Returns |
Biovie Inc vs. TG Therapeutics
Performance |
| Timeline |
| Biovie Inc |
| TG Therapeutics |
Biovie and TG Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Biovie and TG Therapeutics
The main advantage of trading using opposite Biovie and TG Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Biovie position performs unexpectedly, TG Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in TG Therapeutics will offset losses from the drop in TG Therapeutics' long position.| Biovie vs. Inozyme Pharma | Biovie vs. Day One Biopharmaceuticals | Biovie vs. Terns Pharmaceuticals | Biovie vs. Eledon Pharmaceuticals |
| TG Therapeutics vs. Madrigal Pharmaceuticals | TG Therapeutics vs. Terns Pharmaceuticals | TG Therapeutics vs. Hepion Pharmaceuticals | TG Therapeutics vs. Exelixis |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Other Complementary Tools
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Transaction History View history of all your transactions and understand their impact on performance |